Contact
Please use this form to send email to PR contact of this press release:
Senti Bio Reports First Quarter 2025 Financial Results and Provides a Corporate Update on Positive SENTI-202 Clinical Development
TO:
Please use this form to send email to PR contact of this press release:
Senti Bio Reports First Quarter 2025 Financial Results and Provides a Corporate Update on Positive SENTI-202 Clinical Development
TO: